Abstract
Tumoricidal “bystander effect” observed in the herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (GCV) gene therapy was studied between different rat glioma cell lines (9L and C6 cells) under both in vitro and in vivo conditions. For that purpose, mixed populations of wild-type cells (9Lwt and C6wt) and respective HSVtk gene–transduced cells (9Ltk and C6tk) were examined for their sensitivity to GCV. A potent in vitro bystander effect was observed in 9Lwt/9Ltk and 9Lwt/C6tk combinations but not in C6wt/9Ltk and C6wt/C6tk combinations. In vivo bystander effect studied in a subcutaneous tumor model in athymic nude mice was also potent in 9Lwt/9Ltk and 9Lwt/C6tk combinations. Because the expression of connexin43, a major protein in the connexin family gene products, in 9L cells is much higher than that in C6 cells, the results suggest that the amount of connexin in target (wild-type) cells but not in effector ( HSVtk gene–bearing) cells is important for the generation of the bystander effect. This hypothesis was further confirmed by the observation that in vitro bystander effect in C6wt/C6tk combination was potentiated by transduction of the connexin43 gene to the target cells. Cancer Gene Therapy (2001) 8, 414–420
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vile RG, Nelson JA, Castleden S, Chong H, Hart IR . Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component Cancer Res 1994 54: 6228–6234
Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann J-L, Klatzmann D . Regression of established macroscopic liver metastases after in situ transduction of a suicide gene Proc Natl Acad Sci USA 1993 90: 7024–7028
Barba D, Hardin J, Sadelain M, Gage FH . Development of anti-tumor immunity following thymidine kinase–mediated killing of experimental brain tumor Proc Natl Acad Sci USA 1994 91: 4348–4352
Gagandeep S, Brew R, Green B, et al . Prodrug-activated gene therapy: involvement of an immunological component in the “bystander effect.” Cancer Gene Ther 1996 3: 83–88
Samejima Y, Meruelo D . “Bystander killing” induces apoptosis and is inhibited by forskolin Gene Ther 1995 2: 50–58
Freeman SM, Abboud CN, Whartenby KA, et al . The “bystander effect”: tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 1993 53: 5274–5283
Ram Z, Wallbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH . The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature growth of 9L gliomas in rats J Neurosurg 1994 81: 256–260
Zhu D, Caveney S, Kidder GM, Naus CCG . Transfection of C6 glioma with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation Proc Natl Acad Sci USA. 1991 88: 1883–1887
Fick J, Barker FG II, Dazin P, Westphale EM, Beyer EC, Israel MA . The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro Proc Natl Acad Sci USA 1995 92: 11071–11075
Vrionis FD, Wu JK, Qi P, Waltzman M, Cherington V, Spray DC . The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions Gene Ther 1997 4: 577–585
Dilber MS, Abedi MR, Christensson B, et al . Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo Cancer Res 1997 57: 1523–1528
Elshami AA, Saavedra A, Zhang H, et al . Gap junctions play a role in the “bystander effect” of the herpes simplex virus thymidine kinase/ganciclovir system in vitro Gene Ther 1996 3: 85–92
Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H . Bystander killing of cancer cells by herpes simplex virus thymidine kinase is mediated by connexins Proc Natl Acad Sci USA 1996 93: 1831–1835
Shinoura N, Chen L, Wani MA, et al . Protein and messenger RNA expression of connexin43 in astrocytoma: implications in brain tumor gene therapy J Neurosurg 1996 84: 839–846
Marcel T, Grausz JD . The TMC worldwide gene therapy enrollment report, end 1996 Hum Gene Ther 1997 8: 775–800
Tamura M, Shimizu K, Yamada M, Miyao Y, Hayakawa T, Ikenaka K . Targeted killing of migrating glioma cells by injection of HTK-modified glioma cells Hum Gene Ther 1997 8: 381–391
Namba H, Tagawa M, Iwadate Y, Kimura M, Sueyoshi K, Sakiyama S . Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells Hum Gene Ther 1998 9: 5–11
Namba H, Tagawa M, Miyagawa T, Iwadate Y, Sakiyama S . Treatment of rat brain tumor by herpes simplex virus thymidine gene–transduced allogeneic tumor cells and ganciclovir Cancer Gene Ther 2000 7: 947–953
Arienti F, Sule-Suso J, Melani C, et al . Interleukin-2 gene–transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes Hum Gene Ther 1994 5: 1139–1150
Miller AD, Rosman GJ . Improved retroviral vectors for gene transfer and expression BioTechniques 1989 7: 980–990
Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays J Immunol Methods 1983 65: 55–63
Namba H, Iwadate Y, Tagawa M, et al . Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging Hum Gene Ther 1996 7: 1847–1852
Wu JK, Cano WG, Meylaerts SAG, Qi P, Vrionis FD, Cherington V . Bystander tumoricidal effect in the treatment of experimental brain tumors Neurosurgery 1994 35: 1094–1103
Naus CCG, Elisevich K, Zhu D, Belliveau DJ, Maestro RFD . In vivo growth of C6 glioma cells transfected with connexin43 cDNA Cancer Res 1992 52: 4208–4213
Huang R-P, Fan Y, Hossain MZ, Peng A, Zeng Z-L, Boynton AL . Reversion of the neoplastic phenotype of human glioblastoma cells by connexin43 (cn43) Cancer Res 1998 58: 5089–5096
Estin D, Li M, Spray D, Wu JK . Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy Neurosurgery 1999 44: 361–369
Park JY, Elshami AA, Amin K, Rizk K, Kaiser LR, Albelda SM . Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy Gene Therapy 1997 4: 909–917
Carystinos GD, Katabi HM, Laird DW, et al . Cyclic-AMP induction of gap junction intercellular communication increases bystander effect in suicide gene therapy Clin Cancer Res 1999 5: 61–68
Benedetti S, Pirola B, Pollo B, et al . Gene Therapy of experimental brain tumors using neural progenitor cells Nat Med 2000 6: 447–450
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Namba, H., Iwadate, Y., Kawamura, K. et al. Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells. Cancer Gene Ther 8, 414–420 (2001). https://doi.org/10.1038/sj.cgt.7700317
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700317
Keywords
This article is cited by
-
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Stem Cell Research & Therapy (2018)
-
Tumoricidal effect of human olfactory ensheathing cell mediated suicide gene therapy in human glioblastoma cells
Molecular Biology Reports (2018)
-
Assessment of bystander killing-mediated therapy of malignant brain tumors using a multimodal imaging approach
Stem Cell Research & Therapy (2015)
-
The Role of Gap Junction Channels During Physiologic and Pathologic Conditions of the Human Central Nervous System
Journal of Neuroimmune Pharmacology (2012)
-
Cancer gene therapy: Combination with radiation therapy and the role of bystander cell killing in the anti-tumor effect
Pathology & Oncology Research (2006)